Abstract:As an immunogenetic disease susceptibility factor, human leucocyte antigen (HLA) class II loci involve in the pathophysiology of acquired aplastic anaemia (AA) by regulating the immune response and autoreactive T‐cell‐mediated haematopoietic cell death. Distinctive amino acid configurations encoded by the at‐risk HLA alleles enriched in AA patients impact the immune presentation of the peptide repertoire derived from haematopoietic stem/progenitor cells. DRβ‐Ala‐71, DQβ‐Asp‐57 and DRβ‐Gln‐16 are discovered as crucial risk amino acid residues in HLA II class proteins on the onset of AA, as well as associated with paroxysmal nocturnal haemoglobinuria (PNH)‐type cells and pathological somatic or cytogenetic mutations. DRβ‐Ala‐71 and DQβ‐Asp‐57 within the antigen‐binding groove interacting with a more variable antigenic segments, may impact the repertoire of peptides presented, influence the interface HLA‐antigen‐T‐cell receptor β (TCR β). Summary Human leucocyte antigen (HLA) class II molecules are critically involved in the pathology of acquired aplastic anaemia (AA) by regulating the immune response and autoreactive T cell‐mediated haematopoietic cell death. In the study, amino acid residue variation and molecular structure of HLA class II have been initially investigated in 96 patients with AA. The frequencies of residues 9 and 57 in pocket 9 (P9) in DQB1, and amino acid positions 9, 11, 13, 16, 26, 38, 67 and 71 in the P4, P6 and P9 pockets in DRB1 were more prevalent among AA patients. By applying a multivariate recursive approach, the DRβ‐Gln‐16 (OR = 3.003, 95% CI = 1.468–6.145, pc = 0.003), DRβ‐Ala‐71 (OR = 1.924, 95% CI = 1.233–3.002, pc = 0.004) in P4/P7 and DQβ‐Asp‐57 (OR = 3.483, 95% CI = 1.079–11.242, pc = 0.037) in P9, these critical residues were significantly discovered as risk amino acid residues on the onset of AA, as well as associated with PNH‐type cells and pathological somatic or cytogenetic mutations. In silico structural model analysis showed that identified DRβ‐Ala‐71 and DQβ‐Asp‐57 within the antigen‐binding groove interacting with a more variable antigenic segments, may impact the repertoire of peptides presented, influence the interface HLA‐antigen‐T‐cell receptor β (TCR β). These findings provided light on the immunogenetic pathophysiology of AA aetiology and their potential impact on upcoming immunotherapies.

Evolution and diversity of the human leukocyte antigen (HLA)

MHC Locus Variation

Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.

Like wings of a bird: functional divergence and complementarity between HLA-A and HLA-B molecules

Impact of HLA class I functional divergence on HIV control

Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes

Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations

HLAs, TCRs, and KIRs, a Triumvirate of Human Cell-Mediated Immunity

HLA structure and function in hematopoietic-cell transplantation

The Pathogen Adaptation of HLA Alleles and the Correlation with Autoimmune Diseases based on the HLA Diversity Resource in the Han Chinese

[Association of Gene HLA-class I with Leukemia].

Frequency distribution of HLA class I and II alleles in Greek population and their significance in orchestrating the National Donor Registry Program

Human Leukocyte Antigen and Tumor Immunotherapy (Review)

Human herpesvirus diversity is altered in HLA class I binding peptides

An HLA map of the world: A comparison of HLA frequencies in 200 worldwide populations reveals diverse patterns for class I and class II

Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response

Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

Reassessing human MHC-I genetic diversity in T cell studies

Immunogenetic profiles of 9 human herpes virus envelope glycoproteins

Human leukocyte antigen polymorphisms and Kaposi's sarcoma-associated herpesvirus infection outcomes: A call for deeper exploration: FANG et al.